Armata VP Corporate Controller Richard Rychlik to depart on Sept 30, 2024

Armata Pharmaceuticals, Inc.

Richard Rychlik, VP and Corporate Controller, will leave Armata effective September 30, 2024.
Separation agreement terms are still being negotiated between Rychlik and the company.
No successor named; role of Corporate Controller is currently unstaffed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Rychlik

Vice President, Corporate Controller

ARMP · Armata Pharmaceuticals, Inc.

Effective: 2024-09-30
Filed: September 26, 2024, 7:59 PM ET

reached an agreement with Richard Rychlik, the Company’s Vice President, Corporate Controller, pursuant to which Mr. Rychlik’s employment will conclude effective as of September 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Richard Rychlik departed as Vice President, Corporate Controller at Armata Pharmaceuticals, Inc..

Role: Vice President, Corporate Controller

Exact text from the filing

reached an agreement with Richard Rychlik, the Company’s Vice President, Corporate Controller, pursuant to which Mr. Rychlik’s employment will conclude effective as of September 30, 2024.

View on SEC.gov

Armata Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-103160

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.